Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Pilot Study of Namenda (Memantine Hydrochloride) in Adult Subjects With Attention Deficit Hyperactivity Disorder (ADHD) and ADHD NOS

NCT00586573 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT00586573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00586573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Pilot Study of Namenda (Memantine Hydrochloride) in Adult Subjects With Attention Deficit Hyperactivity Disorder (ADHD) and ADHD NOS
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2007
Completion date
October 31, 2009
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adhd